Form 4: Oruka Therapeutics COO Sells Shares
Insider Transaction (Form 4)
Laura Lee Sandler, Chief Operating Officer of Oruka Therapeutics, Inc., sold 5,000 shares of common stock on September 1, 2026.
Summary
- Option exercise/conversion: acquired 5,000 Common Stock at $7.80 ($39,000) on September 1, 2026; holds 241,384 after (Direct).
- Open-market sale: disposed of 1,000 Common Stock at $91.05 ($91,048) on September 1, 2026; holds 240,384 after (Direct).
- Open-market sale: disposed of 4,000 Common Stock at $92.01 ($368,054) on September 1, 2026; holds 236,384 after (Direct).
- Option exercise/conversion: disposed of 5,000 Employee Warrant (right to buy) on September 1, 2026; holds 74,996 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $459,101 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Laura Lee Sandler — Officer (Chief Operating Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Option exercise/conversion | Common Stock | 5,000 | $8 | $39.0K | 241,384 |
| 2026-09-01 | Open-market sale | Common Stock | 1,000 | $91 | $91.0K | 240,384 |
| 2026-09-01 | Open-market sale | Common Stock | 4,000 | $92 | $368.1K | 236,384 |
| 2026-09-01 | Option exercise/conversion | Employee Warrant (right to buy) | 5,000 | — | — | 74,996 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Option exercise/conversion (5,000 shares) |
| 2026-09-01 | Open-market sale (1,000 shares) |
| 2026-09-01 | Open-market sale (4,000 shares) |
| 2026-09-01 | Option exercise/conversion (5,000 shares) |
Keywords
insider transaction, Form 4, ORKA, Oruka Therapeutics, Inc., bearish, Laura Lee Sandler
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.